Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $507,637 | 179 | 95.4% |
| Travel and Lodging | $11,375 | 28 | 2.1% |
| Honoraria | $6,000 | 2 | 1.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,493 | 2 | 1.0% |
| Food and Beverage | $1,595 | 23 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $192,946 | 87 | $0 (2024) |
| GlaxoSmithKline, LLC. | $89,816 | 49 | $0 (2024) |
| Janssen Research & Development, LLC | $57,375 | 3 | $0 (2021) |
| SANOFI PASTEUR INC. | $52,582 | 28 | $0 (2023) |
| ModernaTX, Inc. | $21,886 | 10 | $0 (2023) |
| Janssen Global Services, LLC | $21,840 | 7 | $0 (2022) |
| Dynavax Technologies Corporation | $20,125 | 8 | $0 (2022) |
| Emergent BioSolutions Inc. | $16,850 | 8 | $0 (2023) |
| Valneva USA, Inc. | $12,600 | 4 | $0 (2022) |
| Genentech, Inc. | $9,371 | 8 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $38,496 | 21 | GlaxoSmithKline, LLC. ($18,983) |
| 2023 | $63,262 | 30 | Merck Sharp & Dohme LLC ($36,168) |
| 2022 | $30,348 | 17 | Valneva USA, Inc. ($12,600) |
| 2021 | $147,278 | 40 | Janssen Research & Development, LLC ($57,375) |
| 2020 | $105,545 | 29 | Merck Sharp & Dohme Corporation ($46,250) |
| 2019 | $62,698 | 43 | Merck Sharp & Dohme Corporation ($26,000) |
| 2018 | $60,182 | 26 | Merck Sharp & Dohme Corporation ($24,930) |
| 2017 | $24,291 | 28 | Merck Sharp & Dohme Corporation ($15,625) |
All Payment Transactions
234 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,333.33 | General |
| 12/02/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: VACCINE | ||||||
| 12/02/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $187.50 | General |
| Category: VACCINE | ||||||
| 12/01/2024 | Bavarian Nordic A/S | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 11/05/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $4,200.00 | General |
| 10/30/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 10/29/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 10/09/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $187.50 | General |
| Category: VACCINE | ||||||
| 10/07/2024 | Bavarian Nordic A/S | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 10/02/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Consulting Fee | Cash or cash equivalent | $2,125.00 | General |
| Category: VACCINE | ||||||
| 10/02/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| Category: VACCINE | ||||||
| 09/11/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,560.00 | General |
| Category: VACCINE | ||||||
| 09/11/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $575.00 | General |
| Category: VACCINE | ||||||
| 08/08/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $2,166.67 | General |
| 06/26/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $375.00 | General |
| Category: VACCINE | ||||||
| 06/24/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $877.50 | General |
| Category: VACCINE | ||||||
| 05/07/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $4,200.00 | General |
| 04/29/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Consulting Fee | Cash or cash equivalent | $4,375.00 | General |
| Category: VACCINE | ||||||
| 04/26/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,083.30 | General |
| 04/22/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $875.00 | General |
| Category: VACCINE | ||||||
| 01/08/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Consulting Fee | Cash or cash equivalent | $1,125.00 | General |
| Category: VACCINE | ||||||
| 12/22/2023 | ModernaTX, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| 12/18/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $3,562.50 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/18/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $290.00 | General |
| Category: VACCINE | ||||||
| 12/05/2023 | SANOFI PASTEUR INC. | — | Consulting Fee | Cash or cash equivalent | $3,069.00 | General |
About Dr. Gregory Poland, M.D
Dr. Gregory Poland, M.D is a Internal Medicine healthcare provider based in Rochester, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306824750.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Poland, M.D has received a total of $532,099 in payments from pharmaceutical and medical device companies, with $38,496 received in 2024. These payments were reported across 234 transactions from 17 companies. The most common payment nature is "Consulting Fee" ($507,637).
Practice Information
- Specialty Internal Medicine
- Location Rochester, MN
- Active Since 01/05/2006
- Last Updated 08/19/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1306824750
Products in Payments
- V114 (Biological) $108,305
- SHINGRIX (Biological) $27,047
- NO PRODUCT DISCUSSED (Drug) $22,600
- Heplisav-B (Drug) $20,125
- CAPVAXIVE (Biological) $9,375
- Xofluza (Drug) $9,371
- FLUZONE QUADRIVALENT (Drug) $8,453
- V212 (Biological) $4,500
- MENACTRA (Drug) $3,409
- JYNNEOS (Drug) $2,750
- NOVAVAX COVID-19 VACCINE, ADJUVANTED (Biological) $907.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Rochester
Dr. Ben George, M.d, M.D
Internal Medicine — Payments: $729,795
John Kisiel, M.d, M.D
Internal Medicine — Payments: $550,377
Christopher Ritchlin, Md, MD
Internal Medicine — Payments: $512,889
Scott Feitell, D.o, D.O
Internal Medicine — Payments: $471,187
Prashant Kapoor, Md, MD
Internal Medicine — Payments: $403,295
Irina Bancos, M.d, M.D
Internal Medicine — Payments: $360,053